Independent fund research. Built on SEC filings.

How we research funds

ETF · Health Care Sector · SPDR (State Street)

State Street(R) SPDR(R) S&P(R) Health Care Services ETF (XHS)

Ticker XHS · Index fund · · Holdings as of Jun 30, 2026

Expense ratio
0.35%$35/yr per $10k
5-yr return
+2.3%annualized
1-yr return
+18.7%as of Dec 2025
Net assets
$139.9Mall share classes
Holdings
65

Bottom line

Is XHS a good fund? The bottom line

XHS is an index health care sector ETF from SPDR (State Street).

Annual fees run 0.35% — about $35 a year on every $10,000 invested, cheaper than 91% of health care sector funds we track.

It returned +18.7% over one year, +2.3% a year over five years, +6.9% a year over ten (as of Dec 31, 2025, per its prospectus).

With $140 million in net assets and 65 holdings, its largest position is LifeStance Health Group Inc (2.2%) and the top 10 make up 20.4% of the portfolio.

What stands out

  • Low cost: cheaper than 91% of health care sector peers

What to watch

  • 5-year return in the bottom quarter of its category

Updated Nov 19, 2026

What XHS invests in

The State Street SPDR S&P Health Care Services ETF (the Fund) seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of an index derived from the health care providers and services segment of a U.S. total market composite index.

In seeking to track the performance of the S&P Health Care Services Select Industry Index ? (the Index), the Fund employs a sampling strategy, which means that the Fund is not required to purchase all of the securities represented in the Index. Instead, the Fund may purchase a subset of the securities in the Index in an effort to hold a portfolio of securities with generally the same risk and return characteristics of the Index. The quantity of holdings in the Fund will be based on a number of factors, including asset size of the Fund. Based on its analysis of these factors, SSGA Funds Management, Inc. (SSGA FM or the Adviser), the investment adviser to the Fund, either may invest the Fund's assets in a subset of securities in the Index or may invest the Fund's assets in substantially all of the securities represented in the Index in approximately the same proportions as the Index, as…

From the fund's prospectus (filed Oct 26, 2026).

XHS performance

Fund calendar-year total returns, 2015–2025 2015: +3.2%; 2016: −8.2%; 2017: +17.1%; 2018: +2.6%; 2019: +18.7%; 2020: +33.3%; 2021: +9.8%; 2022: −19.9%; 2023: +5.1%; 2024: +1.9%; 2025: +18.7% +3% 2015 −8% 2016 +17% 2017 +3% 2018 +19% 2019 +33% 2020 +10% 2021 −20% 2022 +5% 2023 +2% 2024 +19% 2025
Fund gain (+) Fund loss (−)
Average annual total returns
1 yr5 yr10 yr
XHS+18.7%+2.3%+6.9%
Health Care Sector median+14.5%+4.2%+7.9%

Source: Fund prospectus, as of Dec 31, 2025

Full XHS performance history →

What XHS costs

On a $10,000 investment, XHS's 0.35% expense ratio costs about $35 a year. The prospectus estimates $443 in total costs over 10 years (assuming 5% annual returns). The median health care sector fund charges 0.96%.

See the full XHS fee table →

XHS top 10 holdings

#Holding% of fund
1LifeStance Health Group Inc2.20%
2Hinge Health Inc2.16%
3NeoGenomics Inc2.09%
4GeneDx Holdings Corp2.04%
5Hims & Hers Health Inc2.02%
6PACS Group Inc2.01%
7Acadia Healthcare Co Inc2.00%
8Brookdale Senior Living Inc1.98%
9Astrana Health Inc1.94%
10Surgery Partners Inc1.91%

Source: SEC Form N-PORT, period ended Jun 30, 2026

The top 10 make up 20.4% of the fund. See all top 25 holdings and asset mix →

Alternatives to XHS

More funds like XHS →

XHS FAQ

What is the expense ratio of XHS?
XHS's expense ratio is 0.35%, which works out to about $35 a year for every $10,000 invested. The prospectus estimates total costs of $443 over 10 years on a $10,000 investment (assuming 5% annual returns).
Is XHS a good investment?
It depends on your goals, but the data points to: low cost: cheaper than 91% of health care sector peers; 5-year return in the bottom quarter of its category. This is general information, not personalized advice.
What does XHS hold?
XHS's largest holdings are LifeStance Health Group Inc (2.2%), Hinge Health Inc (2.2%), NeoGenomics Inc (2.1%), GeneDx Holdings Corp (2.0%), Hims & Hers Health Inc (2.0%). It holds 65 positions in total as of Jun 30, 2026 (SEC Form N-PORT).
What is XHS's 5-year return?
XHS returned +2.3% a year over the five years ending Dec 31, 2025, and +6.9% a year over ten years. Past performance does not guarantee future results.
Who manages XHS?
XHS is offered by SPDR (State Street) through Spdr Series Trust.